Citation Impact

Citing Papers

Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer
2009
Diagnosis and Management of Work-Related Asthma
2008
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Air recirculation and sick building syndrome: a blinded crossover trial.
1994
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis
2013 Standout
Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease
1999
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
2015 StandoutNobel
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
A randomized, double‐blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine‐induced cutaneous responses in healthy adult volunteers
2001
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
1998
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
2003 Standout
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Killing ofAspergillus fumigatusspores by human lung macrophages: a paradoxical effect of heat-labile serum components
1989
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Standardisation of spirometry
2005 Standout
Guidelines for the management of work-related asthma
2012
Assessing the Reversibility of Airway Obstruction
1998
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial
2000
Health and employment after a diagnosis of occupational asthma: a descriptive study
1998
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking
1999
Asthma
2017 Standout
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
1999 Standout
General considerations for lung function testing
2005 Standout
Work life of persons with asthma, rhinitis, and COPD: A study using a national, population-based sample
2006
Occurrence of Occupational Asthma
1993
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
2003
Effects of Long-term Treatment With Corticosteroids in COPD
1996
The global burden of multiple chronic conditions: A narrative review
2018 Standout
Interpretative strategies for lung function tests
2005 Standout
Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study
2003
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials
2002
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
2007 Standout
Standardisation of the measurement of lung volumes
2005 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
2003
Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients
2003
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
2012 Standout
Health surveillance in milling, baking and other food manufacturing operation—five years' experience
1999
Nonspecific and specific bronchial responsiveness in occupational asthma caused by platinum salts after allergen avoidance.
1994
Actual Causes of Death in the United States, 2000
2004 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis
2003
Association between socioeconomic status, weight, age and gender, and the body image and weight control practices of 6- to 19-year-old children and adolescents
2001
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline
2000
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease Using Exhaled Nitric Oxide
2009
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Exhaled Nitric Oxide
2005
Statistical Treatment of Exacerbations in Therapeutic Trials of Chronic Obstructive Pulmonary Disease
2006
Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary Disease
2003
How Can the Microbiologist Help in Diagnosing Neonatal Sepsis?
2012
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction.
1996
Occupational airway sensitizers: an overview on the respective literature
2000
Hazardous air pollutants and asthma.
2002
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
2012
Occupational medicine and toxicology
2006 Standout
An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
1997
Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.
1991
British Guideline on the Management of Asthma
2008
Lung volumes and forced ventilatory flows
1993 Standout
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
2014
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1
1992
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design
1992
Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group
1993
Methodological issues in evaluating measures of health as outcomes for COPD
2003
Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.
1992
Indoor air quality and health
1999 Standout
Pulmonary complications of diabetes mellitus. Pneumonia.
1995
Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive Pulmonary Disease
2000
Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.
1992
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995

Works of D C Weir being referenced

A double‐blind placebo‐controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease
1999
Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.
1991
Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.
1990
Occupational asthma due to soft corrosive soldering fluxes containing zinc chloride and ammonium chloride.
1989
Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy.
1988
Occupational asthma due to oil mists.
1988
Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
1993
Association between risk factors for coronary heart disease in schoolboys and adult mortality rates in the same localities.
1990
Health, employment, and financial outcomes in workers with occupational asthma.
1993
Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.
1990
Occupational asthma due to unheated colophony.
1986
Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.
1991
Rankless by CCL
2026